While I appreciate detailed open discussion about any

New Post Public Reply Private Reply Replies (1) Message Board
EliteYoda BeauBeau #11165

While I appreciate detailed open discussion about any matter involving the company, I do really see how your points have much effect on my estimation that Ironridge has already used roughly 450M shares to churn and retrieve their original loan back (~$700k). Even taking into consideration your two points, of excess and exhorbitant legal fees as well as even lower minimum share prices for Ironridge to use as their conversion/issuance prices, I do not see how it would account for a doubling of my estimation of about 450M shares used all the way up to your estimation of over 800M shares or more.

The verbage used in the rather boiler-plate caption in their 10G is there to simply protect them from not allowing participants to pump up the volume and price for sustained periods of time and Ironridge having to at some point issue new shares into their position which are limited by the then high price which would drastically decrease their share allotment. It is basically stating that on any time Ironridge goes ahead with an "order", the price they CAN use (not "choose" to use) is discounted 70% from the closing price of the day prior to the "order" and that price is not to EXCEED the average of the volume weighted average prices of the five consecutive trading days (so long as the aggregate trading volume exceeds $2.5M) thereafter. This is standard practice for most equity financing in the market. It is nothing new. It just protects the funder so that they know they will be allowed to get the most possible shares based on the long term activity in the stock as possible without having to do an issuance after delaying and waiting a very long time while there may exist incredibly high volume and high prices (which would limit the size of their issuance). Look at this way, if they did not have this kind of protection, then at any time Ironridge "chose" to submit an "order" for another "traunche" of shares, the company or some other participant could spike the volume and price for many consecutive days while they issue shares to Ironridge, and the company would have the excuse of the high volume and high prices to not issue Ironridge very many shares and then once Ironridge obtained the shares the volume and price could drop off a cliff and Ironridge would find it very difficult to ever be able to churn a decent number of shares in order to make back their original loan. This is not rocket science, it is very simple.

 It does not really matter on which exact day between Sept 04 and Sept 26 2012 (or any day in Sept for that matter) Ironridge actually chose to submit the order for the issuance because if you look at all the closing prices for all the days in the month of Sept, they span 0.0017 to 0.0031, even using the lowest price, 70% is 0.0012 and so assuming 143,500,000 shares it would mean about $172K was accounted for instead of my earlier assumption of $300k; that is a difference of about $128k, which if you use the lowest 200 DMA of 0.0019 for all the trading since then it would mean an extra measly 67M shares. If you actually look through my calculations I made today versus what my assumptions were in the November post, there was about a 110M share discrepancy and this 67M shares now fit right into that range of error. Just saying, of course, neither of us is going to know exactly how the issuanced panned out for Ironridge, but IMO it does not make sense that they have not already churned enough shares to make back the original loan or that somehow the A/S needs to be increased in order for Ironridge to be allowed to keep issuing shares. I don't see it. Just my opinions. I think speculating about what exactly the monetary value we can place on "reasonable attorney fees" or how other Ironridge deals panned out with other issuers is just a waste of time. This deal is what we are discussing and it has nothing to do with other funding arrangements made with any other issuer or what happened to the company story for those other stocks. I think your figures are way off, they assume 800M shares or more issued to Ironridge and/or over $1M in funds paid back to Ironridge which I think is total speculation and there is no proof for it and I only know what I know as an investor from filings and shareholder notices and what those suggest for me anyway is that Ironridge has already retrieved their original $700k loan so they may still be left with a 9.9% position of pure profit from that deal but even that is total speculation and even that would mean that no more dilution will take place as a part of the first funding arrangement. Believe what you wish but numbers don't lie only bashers with an agenda lie and I think we have all read exactly what you have been spinning on other boards day in day out. From my perspective it is very suspect for such a known basher to be attempting to act like such reasonable steps are being taken to objectively consider estimates using what appears to be rather speculative fuzzy math.

Do or do not, there is no try.

$RFMK

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Mayors Dialogue 2026: Ningbo Leads in Urban Ideas

Updated Category News Views 153

New Waves in City Collaboration Get this: from November 2 to 5, Ningbo, a key city nestled in east China's Zhejiang Province, is rolling out the red carpet for the 2026 Global Mayors Dialogue. Nearly 200 influential figures zooming into this seaside city isn't just for some aimless chit-chat. At the core, the theme is "Openness and Connectivity for Shared Opportunities."...

Continue Reading
Check Point Q3 2026 Results: Subtle Shifts or a Turning Point?

Updated Category News Views 176

Digging Deeper into Check Point's Latest Figures When Check Point Software Technologies Ltd. (NASDAQ:CHKP) throws numbers at the wall, not everything sticks, but there's always something telling. The Q3 financial results for 2026 are out, and it's a mixed bag—coffee’s getting cold before you parse through it. Revenue and Subscription Dynamics Let's cut to it: total...

Continue Reading
Platinum Equity's Bold Move on Warren Valve: An Analysis

Updated Category News Views 51

A Big Play in the Valve Game Straight out of the industrial playbook, Platinum Equity swoops in with its latest acquisition of Warren Valve, yanking it from the clutches of Allied Group. It's not every day you see a move like this in the flow control world. Yeah, you heard that right—flow control. The kind of business that’s all about ensuring the right stuff gets to...

Continue Reading
Pak Mail Jonesboro Dominates at Annex Brands Convention

Updated Category News Views 44

Small Town, Big Impact at the Annex Brands Shindig From little Jonesboro, Arkansas, comes a thunderous clap for the Kincades, who bagged a bunch of trophies and accolades at the big 2026 Annex Brands National Convention. Tim and Rhonda Kincade, the ones running Pak Mail Jonesboro, didn't just show up—they brought home the bacon with honors piled as high as the Ozarks....

Continue Reading
Anthropic's IPO Spurs Leverage Shares' New ETFs

Updated Category News Views 51

Taking a Gamble on AI's New Kid on the Block Here we stand on the edge of another potential AI stock bonanza. Anthropic’s got its sights set on going public, and folks are lining up to bite into what could be the next big generative AI feast. But it's Leverage Shares by Themes that's setting the scene for something a bit wilder—introducing some juicy leveraged and...

Continue Reading
Paulex Bio's PAL-119 Trials: A New Diabetes Frontier

Updated Category News Views 80

Chasing the Holy Grail in Diabetes Treatment The pursuit of a true remedy for diabetes is almost like hunting for the mythical beast—a challenge that's left plenty of contenders biting the dust over the years. Yet, here's Paulex Bio jumping right into the fray with their groundbreaking PAL-119. They're not just peddling another temporary fix like most on the market;...

Continue Reading
CodeBoxx CrewKit Forge: Decentralizing AI Development

Updated Category News Views 71

Unboxing the Machine: CodeBoxx's Ambitious Move When you're talking about shakin' up the tech world, look no further than CodeBoxx and their CrewKit Forge. Unveiled at the Titan 100 Tampa Bay gala, this AI software factory is a beast—a one-meter cube ready to replace a battalion of developers. Imagine not the sterile data centers but this thing chilling in your office,...

Continue Reading
Abracon Unveils Engineer-Focused Website Features

Updated Category News Views 59

Pushing the Needle in Digital Engagement Some days, the market talk brews hotter than a Texas barbecue, and today it’s Abracon serving up something new. They're tossing engineers a fresh digital bone with revamped website accounts. No bells or whistles, just a clean shot at making techies' lives easier as they tinker and design. It's a world where getting your hands on...

Continue Reading
Virginia Innovation Boosts Startups and Research Growth

Updated Category News Views 132

Virginia's Rising Innovation Ecosystem Virginia, a place you might not expect to hear much about in terms of innovation, is actually shaking things up and making waves on a national scale. Throwing their hat into the innovation arena, Virginia's landed itself a cozy #5 spot for its 'Innovation and Research Ecosystem,' according to Area Development's latest rankings. The...

Continue Reading
Restorative Getaways Aid Grieving Families, Offers Relief

Updated Category News Views 58

Finding Solace in Change: The Power of Stepping Away Grieving a lost child. It’s a trip to hell and back, and for many families, the journey feels endless. The press of everyday life—bills, jobs, commutes—offers no mercy. At times, stepping out of the blur might be the prime move toward healing, and that's where restorative getaways step in. Escaping the Everyday...

Continue Reading

Top 5 Most Recently Viewed Articles

KBR, Inc. Shareholders Urged to Act Before Key Deadline

Updated Category News Views 152

Critical Information for KBR, Inc. Shareholders Investors and stakeholders of KBR, Inc. (NYSE: KBR) are being reminded of an important lead plaintiff deadline approaching on November 18, 2025. This announcement aims to alert shareholders who purchased shares during the designated class period to take necessary action regarding their rights. Details of the Class Action The...

Continue Reading
BBG Opens New Office in Washington, D.C. to Expand Services

Updated Category News Views 187

BBG Expands Into Washington, D.C. with New Office DALLAS - BBG, a prominent entity in the commercial real estate valuation sector, has unveiled its newest office in Washington, D.C. This strategic establishment is spearheaded by Bruce H. Davis, Jr., MAI, SRA, who has joined BBG as the Director for the Northeast Division, bringing with him a wealth of expertise....

Continue Reading
Analyzing Clear Channel Outdoor Holdings' Q2 2025 Performance

Updated Category News Views 191

Clear Channel Outdoor Holdings, Inc. Reports Second Quarter 2025 Results Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) announced its financial results for the quarter ended June 30, 2025. The company reported a solid increase in consolidated revenue, signaling effective management strategies and growth within its advertising sectors. Financial Highlights and...

Continue Reading
Xona Strengthens Cybersecurity Solutions in APAC Region

Updated Category News Views 118

Xona Expands Cybersecurity Services Across APAC Based on recent growth and success in key global markets, leading cybersecurity company Xona Systems is deepening its commitment to provide organizations with secure access to critical infrastructure, including operational technology (OT), information technology (IT), and cloud environments. This strategic decision comes as...

Continue Reading
Leadership Transition at GSK: New Era Begins with Luke Miels

Updated Category News Views 272

Major Leadership Change at GSK plc GSK plc (NYSE: GSK) recently announced the appointment of Luke Miels as the new CEO of GSK. He is set to take over from the current CEO, Dame Emma Walmsley, officially assuming the position on January 1, 2026. Background on Luke Miels Luke has been a valuable part of the GSK team since 2017, where he initially served as the Chief...

Continue Reading